Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

This study has been completed.
Information provided by (Responsible Party):
Yoshihiko Saito, Nara Medical University Identifier:
First received: August 3, 2005
Last updated: October 28, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)